Regulation of IL-12 production by human monocytes and the influence of prostglandin E2

Annals of the New York Academy of Sciences

Volumn 795, Issue , 1996, Pages 147-157

  Van Der Pouw Kraan, T C T M ^a   Boeije, L C M ^a   Snijders, A ^b   Smeenk, R J T ^a   Wijdenes, J ^c   Aarden, L A ^a  

^a CENTRAL LABORATORY   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c Diaclone   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYCLIC AMP; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; LYMPHOTOXIN; PROSTAGLANDIN E2;

ATOPIC DERMATITIS; B LYMPHOCYTE; CANCER; CELL FUNCTION; CONFERENCE PAPER; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERIMMUNOGLOBULINEMIA E; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE ACTIVATION; MICROFILARIASIS; MONOCYTE; NATURAL KILLER CELL; PREGNANCY; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0030480267     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb52663.x     Document Type: Conference Paper

References (41)

1. MOSMANN, T. R. & R. L. COFFMAN. 1989. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7: 145-173.
2. ROMAGNANI, S. 1991. Human Th1 and Th2 subsets: Doubt no more. Immunol. Today 12: 256.
3. 2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181: 775-779.
4. 2 in downregulating the inflammatory immune response. Mol. Med. Today 1: 60.
5. D'ANDREA, A., M. RENGARAJU, N. M. VALIANTE, J. CHEHIMI, M. KUBIN, M. ASTE, S. CHAN, M. KOBAYASHI, D. YOUNG, E. NICKBARG, R. CHIZZONITE, S. F. WOLF & G. TRINCHIERI. 1992. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176: 1387-1398.
6. SCHINDLER, R. & C. A. DINARELLO. 1989. A method for removing interleukin-1- and tumor necrosis factor-inducing substances from bacterial cultures by ultrafiltration with polysulfone. J. Immunol. Methods 116: 159-165.
7. HELLE, M., L. BOEIJE, E. R. DE GROOT, A. DE VOS & L. A. ARDEN. 1991. Sensitive ELISA for interleukin 6. Detection of IL-6 in biological fluids: Synovial fluids and sera. J. Immunol. Methods 138: 47.
8. HACK, C. E., M. HART, R. J. M. STRACK, R. J. M. S. VAN SCHIJNDEL, A. J. M. EERENBERG, J. H. NUIJENS, L. G. THUS & L. A. AARDEN. 1992. Interleukin-8 in sepsis: Relation to shock and inflammatory mediators. Infect. Immun. 60:2835-2842.
9. 2 regulates macrophage-derived tumor necrosis factor gene expression. J. Biol. Chem. 263: 5380-5384.
10. 2. J. Exp. Med. 180:2365-2370.
11. D'ANDREA, A., M. ASTE-AMEZAGA, N. M. VALIANTE, X. MA, M. KUBIN & G. TRINCHIERI. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon-gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178: 1041-1048.
12. FLESCH, I. E. A., J. H. HESS, S. HUANG, M. AGUET, J. ROTHE, H. BLUETHMANN & S. H. E. KAUFMANN. 1995. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon γ and tumor necrosis factor α. J. Exp. Med. 181: 1615-1621.
13. VAN DER POUW KRAAN, T., C. VAN KOOTEN, H. J. A. M. RENSINK & L. A. AARDEN. 1992. IL-4 production by human T cells. Differential regulation of IL-4 versus IL-2 production. Eur. J. Immunol. 22: 1237-1241.
14. 2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J. Immunol. 150: 5321-5329.
15. PHIPPS, R. P., S. H. STEIN & R. L. ROPER. 1991. A new view of prostaglandin E regulation of the immune response. Immunol. Today 12: 349-352.
16. LEUNG, D. Y. M., L. KEY, J. J. STEINBERG, M. C. YOUNG, M. VON DECK, R. WILKINSON & R. S. GEHA. 1988. Increased in vitro bone resorption by monocytes in the hyper-immunoglobulin E syndrome. J. Immunol. 140: 84-88.
17. JACOB, T., B. N. HUSPITH, Y. E. LATCHMAN, R. RYCROFT & J. BROSTOFF. 1990. Depressed lymphocyte transformation and the role of prostaglandins in atopic dermatitis. Clin. Exp. Immunol. 79: 380-384.
18. CHEMINI, J., S. E. STARR, I. FRANK, A. D'ANDREA, X. MA, R. R. MACGREGOR, J. SENNELIER & G. TRINCHIERI. 1994. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J. Exp. Med. 179: 1361-1366.
19. FOLEY, P., F. KAZAZI, R. BITI, T. C. SORRELL & A. L. CUNNINGHAM. 1992. HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids. Immunology 75: 391-397.
20. 2 production by macrophages infected with HIV. Cell. Immunol. 152: 120-130.
21. 2. AIDS 9: 441-445.
22. HOFMANN, B., P. NISHANIAN, T. NGUYEN, M. LIU & J. L. FAHEY. 1993. Restoration of T-cell function in HIV infection by reduction of intracellular cAMP levels with adenosine analogues. AIDS 7: 659-664.
23. TRASK, D. M., S. C. CHAN, S. E. SHERMAN & J. M. HANIFIN. 1988. Altered leukocyte protein kinase activity in atopic dermatitis. J. Invest. Dermatol. 90: 526-531.
24. 2 release from HIV-infected mononuclear phagocytes. Virology 208: 590-600.
25. WAHL, L. M., M. L. CORCORAN, S. W. PYLE, L. O. ARTHUR, A. HAREL-BELLAN & W. L. FARRAR. 1989. Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. Proc. Natl. Acad. Sci. USA 86: 621-625.
26. HOFMANN, B., P. NISHANIAN, T. NGUYEN, P. INSIXIENGMAY & J. L. FAHEY. 1993. Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytes. Proc. Natl. Acad. Sci. USA 90: 6676-6680.
27. 2 produciton by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer. Cancer 72: 491-501.
28. POLLARD, M. & P. H. LUCKERT. 1981. Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine. Science 214: 558-559.
29. YOUNG, M. R. & S. KNIES. 1995. Prostaglandin E production by Lewis lung carcinoma: Mechanism for tumor establishment in vivo. J. Natl. Cancer Inst. 72: 919-922.
30. FULTON, A. M. & G. H. HEPPNER. 1985. Relationship of prostaglandin E and natural killer sensitivity to metastatic potential in murine mammary adenocarcinomas. Cancer Res. 45: 4779-4784.
31. 2 inhibits TNFα release via a mechanism involving IL-10. J. Immunol. 154: 3383-3390.
32. GIOVANNUCCI, E., K. M. EGAN, D. J. HUNTER, M. J. STAMPFER, G. A. COLDITZ, W. C. WILLETT & F. E. SPEIZER. 1995. Aspirin and the risk of colorectal cancer in women. N. Engl. J. Med. 333: 609-614.
33. WEGMANN, T. G., H. LIN, L. GUILBERT & T. R. MOSMANN. 1993. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a Th2 phenomenon? Immunol. Today 14: 353-356.
34. SCODRAS, J. M., R. S. PARHAR, T. G. KENNEDY & P. K. LALA. 1990. Prostaglandin-mediated inactivation of natural killer cells in the murine decidua. Cell. Immunol. 127: 352-367.
35. 2-mediated immunosuppression by first-trimester human decidual cells blocks activation of maternal leukocytes in the decidua with potential anti-trophoblast activity. Cell. Immunol. 120: 61-74.
36. LALA, P. K., J. M. SCODRAS, C. H. GRAHAM, J. J. LYSIAK & R. S. PARHAR. 1990. Activation of maternal killer cells in the pregnant uterus with chronic indomethacin therapy, IL-2 therapy, or a combination therapy is associated with embryonic demise. Cell. Immunol. 127: 368-381.
37. + T-cell subsets. Proc. Natl. Acad. Sci. USA 91: 18-22.
38. LIU, L. X., C. N. SERHAN & P. F. WELLER. 1990. Intravascular filarial parasites elaborate cyclooxygenase-derived eicosanoids. J. Exp. Med. 172: 993-996.
39. KIRKPATRICK, C. E. & J. P. FARRELL. 1987. Experimental cutaneous leishmaniasis. II. A possible role for prostaglandins in exacerbation of disease in Leislimania major-infected Balb/c mice. J. Immunol. 138: 902-907.
40. HEINZEL, F. P., D. S. SCHOENHAUT, R. M. RERKO, L. E. ROSSER & M. K. GATELY. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177: 1505-1509.
41. SYPEK, J. P., C. L. CHUNG, S. E. H. MAYOR, J. F. SUBRAMANYAM, S. J. GOLDMAN, D. SIEBURTH, S. F. WOLF & R. G. SCHAUB. 1993. Resolution of cutaneous leishmaniasis: Interleukin 12 initiates a protective T-helper-1 immune response. J. Exp. Med. 177: 1797-1802.